Royal Sense share price
BSE: 544143Healthcare Equipment & SuppliesSmall Cap
Royal Sense Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2024
Last close ₹72.00up ₹3.60 (5.26%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹68.40.
28 Oct: open ₹66.00, high ₹72.00, low ₹66.00
52-week range of traded prices to 28 Oct 2026
₹65.95Low, 22 Oct 2026₹255.90High, 8 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹39 Cr3,055th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 5.38
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.95
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.32
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,500
Results
Consolidated; ₹ crore.Royal Sense half-yearly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +67.5%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +13.0%
Half year to Mar 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹60 Crup 37.74%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹3.10 Crdown 23.63%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 5.2%
Revenue by half year
Peak revenue ₹60 Cr, half year to Mar 2026; lowest ₹18 Cr, half year to Mar 2024
Net profit by half year, a loss in red
| ₹ crore | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 17.8 | 22.0 | 39.7 | 43.5 | 59.9 |
| Net profit | 1.6 | 2.4 | 4.0 | 4.1 | 3.1 |
| Net margin | 8.9% | 10.8% | 10.0% | 9.3% | 5.2% |
Consolidated. The 5 half years from Mar 2024, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹103 Crup 67.45%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹7.15 Crup 12.99%
- Net margin
- 6.9%
Revenue by year
Peak revenue ₹103 Cr, year to Mar 2026; lowest ₹18 Cr, year to Mar 2024
Net profit by year, a loss in red
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 18 | 62 | 103 |
| Net profit | 2 | 6 | 7 |
| Net margin | 8.9% | 10.3% | 6.9% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Medical Equipments and Supplies, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Royal Sense PE ratio and valuation
Price to earnings
At or below today's level on 4% of 216 trading days over the last year.
LowestHighest
Its median9.65Industry median23.21
Price to book
At or below today's level on 4% of 208 trading days over the last year.
LowestHighest
Its median2.13Industry median2.59
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −36.3% | +4.3% | −38.9% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Royal Sense competitors and peers
Medical Equipment & Supplies, 27 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Royal Sense in market cap. 4 companies in the table last traded before then: their rows are priced on their last trade.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Choksi AsiaCHOKSI | 123 | 23.62 | 2.91 | +21.4% | – | 13.1% | 14.7% | 0.00% |
 Shree PacetronixSHREEPAC | 63 | 19.59 | 3.50 | +22.5% | +210.4% | 20.3% | 21.8% | 0.00% |
 Mohini Health & HygieneMHHL | 49 | – | 0.55 | −13.9% | −382.3% | −17.2% | – | 0.00% |
 Amkay ProductsAMKAY | 46 | 19.85 | 1.74 | +9.5% | −30.8% | 9.2% | – | 0.00% |
 GKB OphthalmicsGKB | 30 | 9.40 | 0.58 | +29.9% | – | 6.2% | 10.5% | 0.00% |
 Galaxy MedicareGML | 27 | 7.99 | 0.68 | – | – | 8.5% | – | 3.89% |
 Centenial Surgical SutureCSURGSU | 26 | – | 0.91 | +6.7% | – | −4.8% | 5.3% | 0.00% |
 Transpact EnterprisesTRANSPACT | 4 | 42.97 | 6.98 | – | – | 17.6% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Royal Sense announcements
Oct 2026
5 Oct · Board meeting
Meeting on 5 Oct 2026
Sep 2026
29 Sep · Meeting
Royal Sense share price by year
Each calendar year to 2025.Royal Sense share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 191.45 | −36.6% | 316.05 | 180.00 |
| 2024 | 301.85 | – | 309.00 | 108.97 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 19 Mar 2024.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | 68.40 | 68.78 | 68.40 | 68.40 | 68.43 | 6,000 |
| 26 Oct 2026 | 68.40 | 68.40 | 68.40 | 68.40 | 68.40 | 4,500 |
| 22 Oct 2026 | 65.95 | 70.00 | 65.95 | 69.95 | 69.86 | 34,000 |
| 21 Oct 2026 | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 | 500 |
| 19 Oct 2026 | 71.00 | 74.00 | 71.00 | 74.00 | 71.75 | 2,000 |
| 16 Oct 2026 | 72.00 | 72.00 | 72.00 | 72.00 | 72.00 | 2,500 |
| 15 Oct 2026 | 71.00 | 74.50 | 68.00 | 68.00 | 69.36 | 3,500 |
| 14 Oct 2026 | 69.60 | 72.00 | 69.60 | 72.00 | 70.10 | 8,500 |
| 13 Oct 2026 | 72.00 | 72.00 | 67.50 | 69.10 | 68.75 | 5,500 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 544143
- ISIN
- INE0QQG01019
- Industry
- Healthcare Equipment & Supplies
- Website
- www.royalsense.in
- CIN
- L21006DL2023PLC412051
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2023
- Registered office
- C-7, Phase-3, Badli Industrial Area, New Delhi 110042, Delhi
- Share registrar
- Bigshare Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments